Literature DB >> 2256844

Pars plana vitrectomy for acute retinal detachment in penetrating ocular injuries.

P E Liggett1, W J Gauderman, C M Moreira, W Barlow, R L Green, S J Ryan.   

Abstract

We studied 41 eyes with acute retinal detachment after penetrating ocular trauma in a retrospective cohort analysis. Pars plana vitrectomy was performed in 28 eyes, while the remaining 13 eyes had only primary repair and closure of the wound. The two groups differed in the type of trauma (more gunshot wounds in the vitrectomy group and more blunt injuries in the nonvitrectomized group). Visual success (visual acuity of 5/200 or better) was observed in 10 (37%) of the eyes treated by vitrectomy compared with one (8%) of the eyes in the nonvitrectomy group. Anatomic success was achieved in 21 (75%) of the eyes in the vitrectomy group but in only one (8%) of those in the nonvitrectomy group. Enucleation or phthisis was observed in seven (54%) of the eyes in the nonvitrectomy group compared with only five (18%) in the vitrectomy group. Significant prognostic factors for anatomic outcome in the vitrectomy group were the location of the laceration and the presence of the lens.

Entities:  

Mesh:

Year:  1990        PMID: 2256844     DOI: 10.1001/archopht.1990.01070140078033

Source DB:  PubMed          Journal:  Arch Ophthalmol        ISSN: 0003-9950


  3 in total

1.  Visual outcomes of vitreoretinal surgery in eyes with severe open-globe injury presenting with no-light-perception vision.

Authors:  Hani Salehi-Had; Christopher M Andreoli; Michael T Andreoli; Carolyn E Kloek; Shizuo Mukai
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2009-01-27       Impact factor: 3.117

2.  [Management of a ruptured globe].

Authors:  A Viestenz; W Schrader; M Küchle; S Walter; W Behrens-Baumann
Journal:  Ophthalmologe       Date:  2008-12       Impact factor: 1.059

3.  A standardized classification of ocular trauma.

Authors:  F Kuhn; R Morris; C D Witherspoon; K Heimann; J B Jeffers; G Treister
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-06       Impact factor: 3.117

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.